Bioconjugation Scientist
2 weeks ago
Piper Companies is currently looking for an experienced Bioconjugation Scientist in Philadelphia, Pennsylvania (PA) to work for an innovative and growing pharmaceutical company. The Bioconjugation Scientist will play a significant role in developing innovative conjugates for the treatment of serious life threating diseases. Responsibilities for the Bioconjugation Scientist include: ·Design, plan, and execute experiments focused on bioconjugate synthesis (e.g., protein–small molecule, protein–peptide, protein–oligonucleotide, and protein–fluorophore conjugates).·Analyze conjugates and biomolecules using LC-MS, HPLC, UV-Vis, SDS-PAGE gels, and RNA gels to assess purity, integrity, and molecular composition.·Maintain proper laboratory documentation within ELM in accordance with GLP/GDP guidelines Qualifications for the Bioconjugation Scientist include:·1- 2 years’ experience with AKTA purification or conjugation ·1-2 years of experience within pharmaceutical research or manufacturing·B.S. in Molecular Biology or scientific field Compensation for the Bioconjugation Scientist include: ·Salary Range is $65,000-$70,000 dependent upon experience·Comprehensive benefits package Keywords Bioconjugation, conjugation, pharmaceutical research, AKTA purification, HPLC, LC-MS, SDS Page, RNA gels, science, design of experiment, DOE, Philadelphia, PA, Pennsylvania, ELN, electric lab notebooks, comprehensive benefits package, Health, Vision, Dental.#LI-ONSITE #LI-DF1
-
Philadelphia, United States Aro Biotherapeutics Full timeAt Aro, we're developing a patented platform technology called Centyrins that are uniquely positioned to achieve precise targeting of diverse therapeutic payloads to specific cells of interest. Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the affinity and specificity properties of antibodies with the...
-
Philadelphia, PA, United States Aro Biotherapeutics Full timeAt Aro, we're developing a patented platform technology called Centyrins that are uniquely positioned to achieve precise targeting of diverse therapeutic payloads to specific cells of interest. Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the affinity and specificity properties of antibodies with the...
-
Philadelphia, PA, United States Aro Biotherapeutics Full timeAt Aro, we're developing a patented platform technology called Centyrins that are uniquely positioned to achieve precise targeting of diverse therapeutic payloads to specific cells of interest. Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the affinity and specificity properties of antibodies with the...
-
Philadelphia, PA, United States Aro Biotherapeutics Full timeAt Aro, we're developing a patented platform technology called Centyrins that are uniquely positioned to achieve precise targeting of diverse therapeutic payloads to specific cells of interest. Centyrins are small protein domains based on the fibronectin domains of human Tenascin C that combine the affinity and specificity properties of antibodies with the...
